Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 9, 2026 · Other material event · Item 5.07 · Financial statements
Arcutis Biotherapeutics, Inc.
7
Other material event
Jun 9, 2026
| Item 5.07 | Item 5.07 |
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
Arcutis Biotherapeutics, Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230. 425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.
This filing reports Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Arcutis Biotherapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
